SPY ETF Falls 0.2%, Outperforms Underlying Index
Dow Jones2026/09/30 20:36This article was automatically generated using Dow Jones technology.
Shares of State Street SPDR S&P 500 ETF Trust dropped 0.2% to $762.63 Wednesday on what proved to be an overall unfavorable trading session for the U.S. stock market, with the S&P 500 Index, the fund's underlying index, falling 0.3% to 7,651.54.
This was the fund's third consecutive day of losses.
The ETF's shares closed 2.1% below the 52-week high of $779.37 seen on August 13, 2026.
Trading volume was 60,296,574, compared to the 65-day average trading volume of 44,486,741.
As of September 29, the fund's net asset value totaled $764.13 per share.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 30, 2026 16:36 ET (20:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks
BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%
Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Crypto prices
More
